MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-33-0227335
Intracell Therapeutics Private Limited - pharma in Thane, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹5 Cr
▲ 680% YoY
Net profit · FY 2024
₹25.7 Lakh
Net margin 5.1%
EBITDA · FY 2024
₹27.24 Lakh
EBITDA margin 5.4%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
13 yrs
Est. 2013
Employees · EPFO
1
Provident fund records
Directors on board
2
As per MCA filings
About Intracell Therapeutics Private Limited
Data last updated:
Intracell Therapeutics Private Limited is a private limited company based in Thane, Maharashtra, India, a subsidiary of Vitane Pharmaceuticals Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 February 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2013PTC240329. Its GSTIN is 27AADCI1863K1ZD (Maharashtra).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Lakh. It is led by directors Mohammed Hussain Sadiq and Mirza Sajjad Baig.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Thane, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹5 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹25.7 Lakh (net margin 5.1%) and EBITDA of ₹27.24 Lakh (EBITDA margin 5.4%). Revenue has grown at a compounded annual rate (CAGR) of 288% over three years and 7% over five years.
The company has about 1 employee on its provident fund (EPFO) records.
Intracell Therapeutics Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0227335). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website intracell.in.
Company details
CIN U24100MH2013PTC240329
Registration Number 240329
Incorporation Date 11 February 2013
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Vitane Pharmaceuticals Private Limited
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-33-0227335
Recognitions & Rankings of Intracell Therapeutics
Contact details
Intracell Therapeutics Private Limited's registered office is in Thane, Maharashtra. Its website is intracell.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressBhoomi Velocity 601 6th Floor Plot No.B39 B39A & B39A1 Road No. 23 MIDC Wagle Es, Tate, Thane, Maharashtra, India – 400604
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Intracell Therapeutics Private Limited, buy the company report.
Comprehensive company report
Intracell Therapeutics Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Intracell Therapeutics is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Intracell Therapeutics Private Limited, buy the company report.
Financials of Intracell Therapeutics Private Limited
FY 2025 filings availableIntracell Therapeutics Private Limited reported revenue of ₹5 Cr (up 680% YoY) for FY 2024.
Revenue · FY 2024
₹5 Cr ▲ 680%
Net profit · FY 2024
₹25.7 Lakh margin 5.1%
EBITDA · FY 2024
₹27.24 Lakh margin 5.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 680%
3 years · compounded
▲ 288%
5 years · compounded
▲ 7%
EBITDA CAGR growth
1 year
▲ 218%
3 years · compounded
▲ 275%
5 years · compounded
▲ 9%
Revenue has grown at a compounded annual rate (CAGR) of 7% over five years, including 680% growth in the latest year. EBITDA rose 218% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹27.24 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹25.7 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.4% | ||||
| Net Profit Margin | 5.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Intracell Therapeutics Private Limited, buy the company report.
Board of directors of Intracell Therapeutics Private Limited
Intracell Therapeutics has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohammed Hussain Sadiq | Director | 11 Feb 2013 | 13 Years 8 Months | Current |
| Mirza Sajjad Baig Also directs: Vitane Pharmaceuticals Private Limited, Vitane Biologics Private Limited, M.S.B Agritech Private Limited and 2 more | Director | 11 Feb 2013 | 13 Years 8 Months | Current |
Peer comparison
Intracell Therapeutics Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pficus De Med Private Limited | ₹5.01 Cr (FY 2024) | 33.0% | Bangalore, Karnataka, India | |||
| Intracell Therapeutics Private Limitedthis company | ₹5 Cr (FY 2024) | ₹25.7 Lakh | 5.1% | 680.0% | 1 | Thane, Maharashtra, India |
| Spark Medicare Private Limited. | ₹5 Cr (FY 2025) | 9.0% | New Delhi, Delhi, India | |||
| Manibro Healthcare Private Limited | ₹5 Cr (FY 2024) | 34.0% | Cuttack, Odisha, India | |||
| Biocruz Pharmaceuticals Private Limited | ₹5 Cr (FY 2025) | 20.0% | Panchkula, Haryana, India |
To see the full peer comparison of Intracell Therapeutics Private Limited, buy the company report.
Auditor
Intracell Therapeutics Private Limited is audited by RS Sawale & Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RS Sawale & Co | FY 2023 | 11996W |
Shareholding
The shareholding of Intracell Therapeutics Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Intracell Therapeutics Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Intracell Therapeutics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Intracell Therapeutics Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 2 overdue payments to 2 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (2 of 2)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| SGN Global Logistics Private Limited | |||
| an individual supplier |
To see the full MSME payment records of Intracell Therapeutics Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Intracell Therapeutics Private Limited has a workforce of 1 employees on its EPFO records as of Jul 25, 2024, across 1 active EPFO establishment.
Employee count
1
Active EPFO establishments
1
Employee growth
-50%
GST
Intracell Therapeutics has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCI1863K1ZD | Maharashtra | Active | 03 Apr 2018 |
To see the full GST registrations and return filing status of Intracell Therapeutics Private Limited, buy the company report.
Recent activity
Intracell Therapeutics Private Limited has 2 board changes on record since 2013: 2 appointments. The latest: Mirza Sajjad Baig was appointed as Director on 11 Feb 2013.
AGM
Intracell Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Intracell Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Appointed
Mirza Sajjad Baig was appointed as Director.
Appointed
Mohammed Hussain Sadiq was appointed as Director.
Incorporation
11 Feb 2013
Intracell Therapeutics Private Limited was registered on 11 Feb 2013 with Roc Mumbai Ii & aged 13 years 8 months as per MCA records.
Frequently asked questions
Intracell Therapeutics is an active private limited company based in Thane, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 February 2013 (13+ years old) and is registered under CIN U24100MH2013PTC240329.
Intracell Therapeutics has 2 current directors:
- Mohammed Hussain Sadiq - Director
- Mirza Sajjad Baig - Director
The latest financial statements of Intracell Therapeutics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Intracell Therapeutics is 27AADCI1863K1ZD, registered in Maharashtra.
The CIN (Corporate Identification Number) of Intracell Therapeutics is U24100MH2013PTC240329. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Intracell Therapeutics was incorporated on 11 February 2013, making it 13+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Intracell Therapeutics by revenue are Pficus De Med Private Limited, Spark Medicare Private Limited, Manibro Healthcare Private Limited, Biocruz Pharmaceuticals Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Mirza Sajjad Baig was appointed as Director on 11 Feb 2013. Mohammed Hussain Sadiq was appointed as Director on 11 Feb 2013.
Yes, Intracell Therapeutics is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-33-0227335).
Intracell Therapeutics has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 2 overdue payments to 2 micro and small suppliers. The latest return was filed on 04 Jul 2024.
Intracell Therapeutics can be reached through the website intracell.in. Its registered office is in Thane, Maharashtra, India.
The registered office of Intracell Therapeutics is at Bhoomi Velocity 601 6th Floor Plot No.B39 B39A & B39A1 Road No. 23 MIDC Wagle Es, Tate, Thane, Maharashtra, India – 400604.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages